Humeral head in rotator cuff tear arthropathy shows reduced cartilage damage and uniform subchondral bone osteoporosis: a histomorphometric analysis

肩袖撕裂性关节病中肱骨头软骨损伤减少,软骨下骨骨质疏松均匀:组织形态计量学分析

阅读:3

Abstract

BACKGROUND: This study histologically assessed alterations in the articular cartilage, subchondral bone, and trabecular bone in patients with rotator cuff tear arthropathy (CTA) versus those with osteoarthritis (OA) of the humeral head. METHODS: This retrospective study evaluated 59 humeral heads (37 CTA and 22 OA cases) resected during shoulder arthroplasty and 7 shoulder specimens from cadaveric controls. Bone density was evaluated by computed tomography. Histological evaluations were analyzed semiquantitatively for Osteoarthritis Research Society International scores, articular cartilage thickness, subchondral bone plate thickness, and trabecular bone mass and distribution, using standard staining techniques. RESULTS: CTA cases showed significantly lower Hounsfield units in the trabecular and metaphyseal bones on the affected side than on the healthy side. In contrast, no significant difference in Hounsfield units was observed in OA cases. A histological analysis showed lower Osteoarthritis Research Society International scores in CTA than in OA, which indicated moderate cartilage degeneration. Subchondral trabecular bone in CTA cases was uniformly thinned, whereas OA cases showed variable trabecular morphology, with areas of both thickening and thinning. Consequently, the humeral head bone volume was smaller in CTA than in OA. CONCLUSION: CTA is characterized by moderate cartilage degeneration and uniform subchondral trabecular bone loss, which may underlie complications associated with reverse shoulder arthroplasty. These findings may serve as a foundation for further studies of appropriate surgical strategies and preoperative interventions for osteoporosis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。